Clinical Trial Update: Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics, safety, tolerability and efficacy of intravenous ZGN-433 in obese female volunteers. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ZGN-433

Snippet

Sponsor: Zafgen, Inc. | Conditions: Obesity | Phase 1 | Status: COMPLETED